GetPortalImpactFactorByIdResp(projectId=1, id=48fa705, cover=https://img.medsci.cn/images/journal/cover/2021/RzI_202109271314486270.jpg, fullname=CURRENT CANCER DRUG TARGETS, abbr=CURR CANCER DRUG TAR, pyear=2001, frequence=Monthly, articleNumbers=1180, citedSelf2015=1.2, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均2.4月, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=1568-0096, greenSci=https://www.greensci.net/search?kw=1568-0096, scijournal=https://www.scijournal.org/impact-factor-of-CURR-CANCER-DRUG-TAR.shtml, medsciHotlightString=null, medsciHotlightRealtime=7.894, medsciHotlight=7.214, medsciHotlight5year=6.33081, citescore=5.3, hIndex=91, impactFactor=3.0, orgnization=Bentham Science Publishers B.V., orgnizationUrl=http://www.bentham.org/, country=United Arab Emirates, countryCn=阿联酋, isOa=1, isOaString=是, sciScie=Science Citation Index Expanded|BIOSIS Previews, bigclassCas=医学 3区, smallclassCas=医学 3 区, website=https://www.eurekaselect.com/journal/ccdt, websiteHits=9002, guideForAuthor=https://www.eurekaselect.com/journal/7/ifa, guideForAuthorHits=318, submitWebsite=https://bentham.manuscriptpoint.com/journals/CCDT, submitWebsiteHits=1872, content=<p>Published by Bentham Science Publishers. ISSN: 1568-0096.</p> <p style="color: #333333;"><strong><em>Current Cancer Drug Targets</em> </strong>aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, <em>e.g.</em> disease specific proteins, receptors, enzymes and genes.</p> <p style="color: #333333;"><strong><em>Current Cancer Drug Targets</em> </strong>publishes original research articles, letters, reviews / mini-reviews, drug clinical trial studies and guest edited thematic issues written by leaders in the field covering a range of current topics on drug targets involved in cancer.</p> <p style="color: #333333;">As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.</p>, totalCites=3540, brief=CURR CANCER DRUG TAR杂志医学行业，“<strong><a target="_blank" href="/sci/index.do?smallclass=肿瘤学" >肿瘤学</a></strong>”子行业的优秀级杂志, articleType=论著为主，其它类型文章约占5-10%, medsciHeat=<span style="color: #990000;">暗红</span>, medsciComment=CURR CANCER DRUG TAR杂志级别还可以，但是相对来说，比较冷门，关注人数偏少，有些可能是国内不太熟悉，但该杂志在国际仍然有相当知晓度的。因为缺少中国人投稿，稿源可能未必丰富，发表有可能有很大的机会哦。, medsciExplanation=MedSci期刊指数是根据中国科研工作者（含医学临床，基础，生物，化学等学科）对SCI杂志的认知度，熟悉程度，以及投稿的量等众多指标综合评定而成。当然，具体的，您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=48fa705'>投稿经验系统</a>”，进行综合判断，这更是大家的实战经验，值得分享和参考。<br> 注意，上述MedSci期刊指数采用MedSci专利技术，由计算机系统自动计算，并给出建议，存在不准确的可能，仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=119, tagName=肿瘤, createdHits=10), ImpactFactorTagDto(id=42480, tagName=肿瘤的分子生物学, createdHits=1), ImpactFactorTagDto(id=42481, tagName=耐药靶点, createdHits=1), ImpactFactorTagDto(id=9721, tagName=药效, createdHits=1), ImpactFactorTagDto(id=3270, tagName=动物模型, createdHits=1), ImpactFactorTagDto(id=42952, tagName=内分泌药理, createdHits=1), ImpactFactorTagDto(id=42953, tagName=肿瘤药理, createdHits=1), ImpactFactorTagDto(id=23003, tagName=药动学, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2016, citescore=3.48), GetImpactFactorCiteScoreListResponse(year=2017, citescore=2.53), GetImpactFactorCiteScoreListResponse(year=2018, citescore=2.16), GetImpactFactorCiteScoreListResponse(year=2019, citescore=4.8), GetImpactFactorCiteScoreListResponse(year=2020, citescore=5.3)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=5.755), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=7.14), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=7.078), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=7.793), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=7.894)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Pharmacology, Toxicology and Pharmaceutics - Pharmacology , rank=140/300), GetImpactFactorCiteScoreGradeResponse(smallClass=Pharmacology, Toxicology and Pharmaceutics - Drug Discovery , rank=70/146), GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Oncology , rank=163/321), GetImpactFactorCiteScoreGradeResponse(smallClass=Biochemistry, Genetics and Molecular Biology - Cancer Research , rank=125/191)], totalJcrAreaList=[GetImpactFactorCiteScoreGradeResponse(smallClass=ONCOLOGY, rank=Q2)], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1568-0096[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=CURRENT CANCER DRUG TARGETS[ta], article_number=68, article_number_cn=29, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)